凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
华兰生物(002007)公告正文

华兰生物工程股份有限公司2005年第三季度报告

公告日期 2005-10-15
股票简称:华兰生物 股票代码:002007

                  华兰生物工程股份有限公司2005年第三季度报告
    
    §1  重要提示
    1.1  本公司董事会及其董事保证本报告所载资料不存在任何虚假记载、误导
性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性负个别及连带责任。
    1.2  没有董事对季度报告内容的真实性、准确性、完整性无法保证或存在异
议。1.3  所有董事均出席董事会
1.4  本报告期财务报告未经审计
1.5  公司董事长安康先生、财务总监王启平先生声明:保证季度报告中财务报告

真实、完整。
§2  公司基本情况
2.1  基本情况简介
   股票简称                             华兰生物                          
股票代码                                                              2007
上市证券交易所                                             深圳证券交易所 
                           董事会秘书  证券事务代表  投资者关系管理负责人 
姓名                             范蓓             /                  安康 
联系地址          新乡市华兰大道甲1号             /   新乡市华兰大道甲1号 
电话                     0373-5056905             /          0373-5056905 
传真                     0373-5056911             /          0373-5056911 
电子信箱         hualan@hualanbio.com             /  hualan@hualanbio.com 
2.2  财务资料
2.2.1  主要会计数据及财务指标
单位:(人民币)元
                      本报告期末      上年度期末     
总资产               604,253,493.95    644,014,832.49
股东权益(不含少数                                   
股东权益)           514,770,043.00    500,480,766.60
每股净资产                    5.122              7.47
调整后的每股净资产            5.119             7.467
                            报告期  年初至报告期期末 
经营活动产生的现金                                   
流量净额              23,163,910.63     77,516,812.00
每股收益                      0.181             0.409
每股收益(注)                0.181                - 
净资产收益率                  3.54%             7.98%
扣除非经常性损益后                                   
的净资产收益率                3.54%             8.02%
                    本报告期末比上年度期末增 
                            减(%)         
总资产                                 -6.17%
股东权益(不含少数                           
股东权益)                              2.86%
每股净资产                            -31.43%
调整后的每股净资产                    -31.45%
                       本报告期比上年同期增减
                                      (%) 
经营活动产生的现金                           
流量净额                              157.07%
每股收益                              126.25%
每股收益(注)                             - 
净资产收益率                            2.44%
扣除非经常性损益后                           
的净资产收益率                          2.45%
注:上年同期公司总股本为6,700万股。截止本报告期末公司总股本为10,050万股

非经常性损益项目     金额     
营业外收支净额     -211,862.75
扣除所得税影响       31,779.41
合计               -180,083.34
2.2.2  财务报表
2.2.2.1  资产负债表
单位:(人民币)元
境内报表
             项目                   期末数       上年度期末   
流动资产:                                                    
  货币资金                       154,123,603.08 226,225,607.52
  短期投资                                                    
  应收票据                         9,255,936.60  23,632,723.89
  应收股利                                                    
  应收利息                                                    
  应收账款                        73,341,209.90  65,024,322.41
  其他应收款                       5,672,795.92   6,378,845.77
  预付账款                        31,779,779.17  28,778,794.71
  应收补贴款                                                  
  存货                            82,883,565.10 108,640,484.17
  待摊费用                           264,093.08     182,545.86
  一年内到期的长期债权投资                                    
  其他流动资产                                                
  流动资产合计                   357,320,982.85 458,863,324.33
长期投资:                                                    
  长期股权投资                    83,740,000.00  49,740,000.00
  长期债权投资                                                
  长期投资合计                    83,740,000.00  49,740,000.00
  合并价差                                                    
固定资产:                                                    
  固定资产原价                   151,373,680.57 146,841,941.27
    减:累计折旧                  56,928,737.47  51,268,837.94
  固定资产净值                    94,444,943.10  95,573,103.33
    减:固定资产减值准备                                      
  固定资产净额                    94,444,943.10  95,573,103.33
  工程物资                                                    
  在建工程                        55,622,107.45  25,825,132.26
  固定资产清理                                                
  固定资产合计                   150,067,050.55 121,398,235.59
无形资产及其他资产:                                          
  无形资产                        13,125,460.55  14,013,272.57
  长期待摊费用                                                
  其他长期资产                                                
  无形资产及其他资产合计          13,125,460.55  14,013,272.57
递延税项:                                                    
  递延税款借项                                                
资产总计                         604,253,493.95 644,014,832.49
流动负债:                                                    
  短期借款                                                    
  应付票据                         4,363,975.00               
  应付账款                        29,054,764.93  37,861,176.61
  预收账款                        12,403,428.38   5,936,737.63
  应付工资                                                    
  应付福利费                      11,863,318.62  12,115,135.78
  应付股利                           900,000.00               
  应交税金                         8,340,139.59   6,387,987.84
  其他应交款                                                  
  其他应付款                      14,917,824.43   3,593,028.03
  预提费用                                                    
  预计负债                                                    
  一年内到期的长期负债                           15,000,000.00
  其他流动负债                                                
  流动负债合计                    81,843,450.95  80,894,065.89
长期负债:                                                    
  长期借款                                       55,000,000.00
  应付债券                                                    
  长期应付款                                                  
  专项应付款                       7,640,000.00   7,640,000.00
  其他长期负债                                                
  长期负债合计                     7,640,000.00  62,640,000.00
递延税项:                                                    
  递延税款贷项                                                
负债合计                          89,483,450.95 143,534,065.89
少数股东权益                                                  
所有者权益(或股东权益):                                    
  实收资本(或股本)             100,500,000.00  67,000,000.00
    减:已归还投资                                            
  实收资本(或股本)净额         100,500,000.00  67,000,000.00
  资本公积                       276,618,468.90 310,118,468.90
  盈余公积                        18,676,632.68  18,676,632.68
    其中:法定公益金               6,259,326.12   6,259,326.12
  未分配利润                     118,974,941.42 104,685,665.02
    其中:现金股利                                            
  未确认的投资损失                                            
  外币报表折算差额                                            
  所有者权益(或股东权益)合计   514,770,043.00 500,480,766.60
负债和所有者权益(或股东权益)                                
合计                             604,253,493.95 644,014,832.49
2.2.2.2  本报告期利润及利润分配表
单位:(人民币)元
境内报表
             项目                    本期        上年同期    
一、主营业务收入                  85,670,395.59 74,360,618.76
  减:主营业务成本                51,167,311.04 52,543,039.57
      主营业务税金及附加                                     
二、主营业务利润(亏损以“-”                                
号填列)                          34,503,084.55 21,817,579.19
  加:其他业务利润(亏损以“-”                              
号填列)                             337,801.78         10.97
  减:营业费用                    10,760,468.08 10,766,791.32
      管理费用                     2,726,398.49  3,316,318.10
      财务费用                       -60,810.53  1,453,473.37
三、营业利润(亏损以“-”号填                                
列)                              21,414,830.29  6,281,007.37
  加:投资收益(亏损以“-”号                                
填列)                                                       
      补贴收入                                               
      营业外收入                       2,624.00     12,840.00
  减:营业外支出                       4,680.00    -20,745.37
四、利润总额(亏损以“-”号填                                
列)                              21,412,774.29  6,314,592.74
  减:所得税                       3,211,916.15    947,188.91
      少数股东损益                                           
  加:未确认的投资损失本期发生                               
额                                                           
五、净利润(亏损以“-”号填列)   18,200,858.14  5,367,403.83
  加:年初未分配利润             100,774,083.28 93,700,840.00
      其他转入                                               
六、可供分配的利润               118,974,941.42 99,068,243.83
  减:提取法定盈余公积                                       
      提取法定公益金                                         
      提取职工奖励及福利基金                                 
      提取储备基金                                           
      提取企业发展基金                                       
      利润归还投资                                           
七、可供投资者分配的利润         118,974,941.42 99,068,243.83
  减:应付优先股股利                                         
      提取任意盈余公积                                       
      应付普通股股利                                         
      转作资本(或股本)的普通                               
股股利                                                       
八、未分配利润                   118,974,941.42 99,068,243.83
利润表(补充资料)                                           
  1.出售、处置部门或被投资单                                
位所得收益                                                   
  2.自然灾害发生的损失                                      
  3.会计政策变更增加(或减少)                              
利润总额                                                     
  4.会计估计变更增加(或减少)                              
利润总额                                                     
  5.债务重组损失                                            
  6.其他                                                    
2.2.2.3  年初到报告期末利润及利润分配表
单位:(人民币)元
境内报表
              项目                年初到报告期末     上年同期    
一、主营业务收入                    259,399,786.12 238,243,200.74
  减:主营业务成本                  174,207,535.15 163,279,409.46
      主营业务税金及附加                                         
二、主营业务利润(亏损以“-”号      85,192,250.97  74,963,791.28
填列)                                                           
  加:其他业务利润(亏损以“-”         969,760.83       7,204.24
号填列)                                                         
  减:营业费用                       25,800,232.65  28,737,814.44
      管理费用                       11,096,885.94   8,721,311.42
      财务费用                          712,705.27   6,878,733.26
三、营业利润(亏损以“-”号填列)    48,552,187.94  30,633,136.40
  加:投资收益(亏损以“-”号填                                  
列)                                                             
      补贴收入                                                   
      营业外收入                          2,649.00     462,386.42
  减:营业外支出                        214,511.75     131,053.63
四、利润总额(亏损以“-”号填列)    48,340,325.19  30,964,469.19
  减:所得税                          7,251,048.79   1,427,370.64
      少数股东损益                                               
  加:未确认的投资损失本期发生                                   
额                                                               
五、净利润(亏损以“-”号填列)      41,089,276.40  29,537,098.55
  加:年初未分配利润                104,685,665.02  69,531,145.28
      其他转入                                                   
六、可供分配的利润                  145,774,941.42  99,068,243.83
  减:提取法定盈余公积                                           
      提取法定公益金                                             
      提取职工奖励及福利基金                                     
      提取储备基金                                               
      提取企业发展基金                                           
      利润归还投资                                               
七、可供投资者分配的利润            145,774,941.42  99,068,243.83
  减:应付优先股股利                                             
      提取任意盈余公积                                           
      应付普通股股利                 26,800,000.00               
      转作资本(或股本)的普通                                   
股股利                                                           
八、未分配利润                      118,974,941.42  99,068,243.83
利润表(补充资料)                                               
  1.出售、处置部门或被投资单位                                  
所得收益                                                         
  2.自然灾害发生的损失                                          
  3.会计政策变更增加(或减少)                                  
利润总额                                                         
  4.会计估计变更增加(或减少)                                  
利润总额                                                         
  5.债务重组损失                                                
  6.其他                                                        
2.2.2.4  年初到报告期末现金流量表
单位:(人民币)元
境内报表
                             项目                               年初到报告期末  
一、经营活动产生的现金流量:                                                    
  销售产品、提供劳务收到的现金                                    317,772,537.90
  收到的税费返还                                                                
  收到的其他与经营活动有关的现金                                      612,878.04
        现金流入小计                                              318,385,415.94
  购买商品、接受劳务支付的现金                                    164,977,827.22
  支付给职工以及为职工支付的现金                                   10,259,261.98
  支付的各项税费                                                   43,697,308.94
  支付的其他与经营活动有关的现金                                   21,934,205.80
        现金流出小计                                              240,868,603.94
  经营活动产生的现金流量净额                                       77,516,812.00
二、投资活动产生的现金流量:                                                    
  收回投资所收到的现金                                                          
  取得投资收益所收到的现金                                                      
  处置固定资产、无形资产和其他长期资产所收回的现金净额                 13,500.00
  收到的其他与投资活动有关的现金                                                
        现金流入小计                                                   13,500.00
  购建固定资产、无形资产和其他长期资产所支付的现金                 10,623,314.26
  投资所支付的现金                                                 34,000,000.00
  支付的其他与投资活动有关的现金                                    9,569,094.85
        现金流出小计                                               54,192,409.11
  投资活动产生的现金流量净额                                      -54,178,909.11
三、筹资活动产生的现金流量:                                                    
  吸收投资所收到的现金                                                          
  借款所收到的现金                                                 35,000,000.00
  收到的其他与筹资活动有关的现金                                                
        现金流入小计                                               35,000,000.00
  偿还债务所支付的现金                                            105,000,000.00
  分配股利、利润或偿付利息所支付的现金                             25,439,907.33
  支付的其他与筹资活动有关的现金                                                
        现金流出小计                                              130,439,907.33
  筹资活动产生的现金流量净额                                      -95,439,907.33
四、汇率变动对现金的影响                                                        
五、现金及现金等价物净增加额                                      -72,102,004.44
现金流量表补充资料                                                              
  1.将净利润调节为经营活动现金流量:                                           
    净利润                                                         41,089,276.40
    加:计提的资产减值准备                                            190,790.87
        固定资产折旧                                                8,617,445.62
        无形资产摊销                                                  887,812.02
        长期待摊费用摊销                                                        
        待摊费用减少(减:增加)                                      -81,547.22
        预提费用增加(减:减少)                                                
        处置固定资产、无形资产和其他长期资产的损失(减:收益)         34,531.75
        固定资产报废损失                                                        
        财务费用                                                    1,290,850.85
        投资损失(减:收益)                                                    
        递延税款贷项(减:借项)                                                
        存货的减少(减:增加)                                     25,756,919.07
        经营性应收项目的减少(减:增加)                           15,124,883.06
        经营性应付项目的增加(减:减少)                          -15,394,150.42
        其他                                                                    
        少数股东损益                                                            
    经营活动产生的现金流量净额                                     77,516,812.00
  2.不涉及现金收支的投资和筹资活动:                                           
    债务转为资本                                                                
    一年内到期的可转换公司债券                                                  
    融资租入固定资产                                                            
  3.现金及现金等价物净增加情况:                                               
    现金的期末余额                                                154,123,603.08
    减:现金的期初余额                                            226,225,607.52
    加:现金等价物期末余额                                                      
    减:现金等价物期初余额                                                      
    现金及现金等价物净增加额                                      -72,102,004.44
2.3  报告期末股东总数及前十名流通股股东持股情况表
       报告期末股东总数                             10,274                     
前十名流通股股东持股情况                                                       
股东名称(全称)                 期末持有流通股的数量  种类(A、B、H股或其它) 
中国工商银行-金泰证券投资基金            1,777,853.00                     A股 
中国建设银行-国泰金马稳健回报                                                 
证券投资基金                              1,009,712.00                     A股 
东方证券-农行-东方红1号集合资                                                
产管理计划                                1,000,000.00                     A股 
中国工商银行-国联安德盛小盘精                                                 
选证券投资基金                              980,850.00                     A股 
中国工商银行-广发聚富开放式证                                                 
券投资基金                                  929,452.00                     A股 
中国工商银行-广发稳健增长证券                                                 
投资基金                                    735,500.00                     A股 
中国建设银行-长城久恒平衡型证                                                 
券投资基金                                  672,954.00                     A股 
东方证券-农行-LEHMAN BROTHERS                                                
INTERNATIONAL (EUROPE)                      663,915.00                     A股 
中国银行-金鹰成份股优选证券投                                                 
资基金                                      616,886.00                     A股 
全国社保基金一零一组合                      516,961.00                     A股 
    §3  管理层讨论与分析
    3.1  公司报告期内经营活动总体状况的简要分析
    本报告期内,公司主导产品人血白蛋白价格大幅上涨,公司实现主营业务收入
8,567.04万元,主营业务利润3,450.31万元,净利润1,820.09万元,分别比去年同
期增长15.21%、58.14%和239.10%。
2005年1-9月份,公司累计实现主营业务收入25,939.98万元、主营业务利润8,519.
23
万元、净利润4,108.93万元,分别比上年同期增长8.88%、13.64%和39.11%。
3.1.1  占主营收入或主营业务利润总额10%以上的主营行业或产品情况
√适用□不适用
单位:(人民币)万元
                     主营业务分行业情况                       
                     主营业务收入  主营业务成本  毛利率(%) 
其他行业                  8,567.04      5,116.73        40.27%
其中:关联交易                   0             0         0.00%
主营业务分产品情况                                            
人血白蛋白                6,387.69      3,421.15        46.44%
静注丙球                    860.01        672.96        21.75%
人免疫球蛋白                109.28        184.38       -68.72%
凝血酶原复合物              418.14        281.05        32.79%
破伤风免疫球蛋白            568.77        410.54        27.82%
其他                        223.15        146.65        34.28%
其中:关联交易                   0             0         0.00%
    3.1.2  公司经营的季节性或周期性特征
    □适用√不适用
    3.1.3  报告期利润构成情况(主营业务利润、其他业务利润、期间费用、投
资收益、补贴收入与营业外收支净额在利润总额中所占比例与前一报告期相比的重
大变动及原因的说
    明)
    □适用√不适用
    3.1.4  主营业务及其结构与前一报告期相比发生重大变化的情况及原因说明
    □适用√不适用
    3.1.5  主营业务盈利能力(毛利率)与前一报告期相比发生重大变化的情况
及其原因说明
    √适用□不适用
    1、本报告期较前一报告期主营业务盈利能力大幅上涨主要原因为:主导产品
人血白蛋白平均售价较前一报告期大幅上涨。
    3.2  重大事项及其影响和解决方案的分析说明
    开展投资者关系管理的具体情况
    1、公司证券部平时主要通过电话、传真、电子邮件等方式回答广大投资者的
咨询,使投资者及时了解公司生产经营情况。
    2、2005年9月中旬,公司组织机构投资者对公司进行调研,增进机构投资者对
公司的了解。
    3、2005年9月19日,公司通过网上远程路演的方式与广大投资者进行沟通和交
流,征求广大投资者对公司股权分置改革的意见。
    其他重大事项及其影响和解决方案的分析说明
    2005年8月20日公司召开了第二届董事会第九次会议。会议审议通过了以下议
案:
    1、公司2005年半年度报告;
    2、邹方霖先生辞去公司董事职务的议案;
    3、增补王启平先生公司董事的预案;
    4、聘任林小军先生为公司总经理的议案;
    5、关于提名范蓓女士为常务副总经理的议案;
    6、关于部分闲置募集资金补充流动资金的议案。
    以上有关事项的公告刊登在巨潮资讯网(http://www.cninfo.com.cn)及证券
时报,请投资者查阅。
    3.3  会计政策、会计估计、合并范围变化以及重大会计差错的情况及原因说

    □适用√不适用
    3.4  经审计且被出具“非标意见”情况下董事会和监事会出具的相关说明
    □适用√不适用
    3.5  预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相
比发生大幅度变动的警示及原因说明
    □适用√不适用
    3.6  公司对已披露的年度经营计划或预算的滚动调整情况
    □适用√不适用
    3.7  原非流通股东在股权分置改革过程中做出的特殊承诺及其履行情况
    □适用√不适用
    华兰生物工程股份有限公司
    董事长:安康
    二零零五年十月十三日
数据加载中...
prevnext
手机查看股票